An Analysis of GlaxoSmithKline

11293 Words23 Pages

An Analysis of GlaxoSmithKline

The business that I have done research into is GlaxoSmithKline. This

company is a globalised research-based pharmaceutical public limited

company. Its ownership structure has changed a great deal since the

original company was first established in 1715. Originally a pharmacy,

the company has expanded, merged with and taken over other companies

over the decades. The last of these was the merger between Glaxo

Wellcome and SmithKline Beecham, which formed the current company of

GlaxoSmithKline.

GlaxoSmithKline’s business is to discover effective medicines and

healthcare products for people throughout the world and create

shareholder value. They are one of the world’s leading producers of

prescription medicines, vaccines and consumer healthcare products

(Toiletries, Drinks). These products include SEROXAT/PAXIL, AUGMENTIN,

WELLBUTRIN and ZOTRAN, all of which are pharmaceutical products.

AQUAFRESH, LUCOZADE, NIQUITIN CQ and SENSODYNE, these are known as

consumer healthcare products. HEPATITUS and INFANRIX, which are

vaccines. The company provides over 7% of the total global

pharmaceutical sales and supply 24% of the world’s vaccines. They

manufacture and distribute more than 10 million packs of medicine

every day.

GlaxoSmithKline now has a Board of 13 Directors, and a further 15

members of The Corporate Executive Team. These members are the

Presidents of the various global and national departments.

Below I have set out a table to show the Advantages and Disadvantages

of a public limited company.

ADVANTAGES

DISADVANTAGES

Shares offered for sale on the stock exchange, so that large amounts

of capital can be generated.

Shareholders protected by limited liabilit...

... middle of paper ...

...ibit the already

efficient practices from continuing. This would therefore have a

knock-on effect to reduce the overall production sites and

effectiveness of the other parts of the company.

The practices already in place help the Group to achieve its

objectives by;

Continually reviewing its source of supply-This meets the objective

of focus on performance, supply and cost

Continually applying quality management-This meets the objectives of

absolute attention to compliance and team work and talent expression

Continually benchmarking other companies- This meets the objective of

focusing on their own performances to meet the aim of being a world

leader.

Continually reviewing its practices through out the Operational

Excellence program- This meets the objective of streamlining the

processes used within the GMS

Bibliography

1) WWW.GSK.CO.UK

Open Document